Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?

BACKGROUND: The treatment of borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) has evolved with a wider application of neoadjuvant chemotherapy (NACHT). The aim of this study was to identify predictive factors for survival in BR and LA PDAC. METHODS: Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: de Carvalho, Luís Filipe Abreu, Gryspeerdt, Filip, Rashidian, Niki, Van Hove, Kobe, Maertens, Lambertine, Ribeiro, Suzane, Hoorens, Anne, Berrevoet, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541717/
https://www.ncbi.nlm.nih.gov/pubmed/37775737
http://dx.doi.org/10.1186/s12893-023-02200-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541717/
https://www.ncbi.nlm.nih.gov/pubmed/37775737
http://dx.doi.org/10.1186/s12893-023-02200-6

Ejemplares similares